Retina dose as a predictor for visual acuity loss in 106Ru eye plaque brachytherapy of uveal melanomas.
CONCLUSION: The study showed that retina dose (D2% and Dmean) is a suitable predictor for VA loss.
PMID: 29452902 [PubMed - as supplied by publisher]
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - Category: Radiology Authors: Heilemann G, Fetty L, Blaickner M, Nesvacil N, Zehetmayer M, Georg D, Dunavoelgyi R Tags: Radiother Oncol Source Type: research
More News: Brachytherapy | Cancer & Oncology | Eye Cancers | Radiology | Study | Uveal Melanoma | Vitamin A